What does Dr. Barbel Aspeslagh do?

Dr. Barbel Aspeslagh is a specialist medical practice in Zedelgem. Private Limited, started on 28 September 2021, 1 establishment.

What is the address of Dr. Barbel Aspeslagh?

The registered office of Dr. Barbel Aspeslagh is located at Baesveld 6, 8210 Zedelgem.

Is Dr. Barbel Aspeslagh still active?

Yes. According to the CBE (26 September 2026) Dr. Barbel Aspeslagh is active, legal situation “Normale toestand”, started on 28 September 2021.

Is Dr. Barbel Aspeslagh registered on Peppol?

Yes, Dr. Barbel Aspeslagh is registered on the Peppol network with ID 0208:0774665952.

What is the enterprise number of Dr. Barbel Aspeslagh?

The enterprise number of Dr. Barbel Aspeslagh is BE0774665952.

When was Dr. Barbel Aspeslagh founded?

Dr. Barbel Aspeslagh was founded on 28 September 2021.

Who are the directors of Dr. Barbel Aspeslagh?

According to the 2025 annual accounts, the directors of Dr. Barbel Aspeslagh are: Barbel ASPESLAGH.

Is Dr. Barbel Aspeslagh a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 September 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Barbel Aspeslagh make in 2025?

Dr. Barbel Aspeslagh posted a profit after taxes of € 141,702 in financial year 2025.

What is the revenue of Dr. Barbel Aspeslagh?

As a small company, Dr. Barbel Aspeslagh is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 185,774.

Dr. Barbel Aspeslagh (Private Limited) - Zedelgem

Dossier Dr. Barbel Aspeslagh, printed on 26 September 2026 from databakkes.be/en/0774665952/dr-barbel-aspeslagh. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Barbel Aspeslagh from Zedelgem, company number BE0774665952, closed financial year 2025 with a result of € 141,702 after tax. For that financial year Dr. Barbel Aspeslagh recorded a gross margin of € 185,774 and equity of € 4,670. Compared with financial year 2024, the result moved from € 149,541 to € 141,702. The company is profitable. The buffer shrank hard: equity is 97 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.

What it is worth Shrank hard

€ 4,670

▼ 97% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 141,702

▼ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 24,368

▼ 73% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 292,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,365

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 28,515

▲ € 25,005 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 49,283 Gross margin 2022: € 49,283 First fiscal year in the series	€ 286,501 Gross margin 2023: € 286,501 ▲ € 237,218 vs 2022 (€ 49,283) Favourable step	€ 196,029 Gross margin 2024: € 196,029 ▼ 32% vs 2023 (€ 286,501) Unfavourable step	€ 185,774 Gross margin 2025: € 185,774 ▼ 5% vs 2024 (€ 196,029) Unfavourable step	▼ 5%
Profit after taxes	€ 37,850 Profit after taxes 2022: € 37,850 First fiscal year in the series	€ 217,252 Profit after taxes 2023: € 217,252 ▲ € 179,402 vs 2022 (€ 37,850) Favourable step	€ 149,541 Profit after taxes 2024: € 149,541 ▼ 31% vs 2023 (€ 217,252) Unfavourable step	€ 141,702 Profit after taxes 2025: € 141,702 ▼ 5% vs 2024 (€ 149,541) Unfavourable step	▼ 5%
Equity	€ 58,176 Equity 2022: € 58,176 First fiscal year in the series	€ 275,427 Equity 2023: € 275,427 ▲ € 217,252 vs 2022 (€ 58,176) Favourable step	€ 154,968 Equity 2024: € 154,968 ▼ 44% vs 2023 (€ 275,427) Unfavourable step	€ 4,670 Equity 2025: € 4,670 ▼ 97% vs 2024 (€ 154,968) Unfavourable step	▼ 97%
Total debts	€ 17,222 Total debts 2022: € 17,222 First fiscal year in the series	€ 32,554 Total debts 2023: € 32,554 ▲ 89% vs 2022 (€ 17,222) Unfavourable step	€ 3,567 Total debts 2024: € 3,567 ▼ 89% vs 2023 (€ 32,554) Favourable step	€ 202,191 Total debts 2025: € 202,191 ▲ € 198,624 vs 2024 (€ 3,567) Unfavourable step	▲ € 198,624
Cash	€ 65,551 Cash 2022: € 65,551 First fiscal year in the series	€ 157,900 Cash 2023: € 157,900 ▲ 141% vs 2022 (€ 65,551) Favourable step	€ 89,440 Cash 2024: € 89,440 ▼ 43% vs 2023 (€ 157,900) Unfavourable step	€ 24,368 Cash 2025: € 24,368 ▼ 73% vs 2024 (€ 89,440) Unfavourable step	▼ 73%
Retained profit	€ 55,676 Retained profit 2022: € 55,676 First fiscal year in the series	€ 272,927 Retained profit 2023: € 272,927 ▲ € 217,252 vs 2022 (€ 55,676) Favourable step	€ 152,468 Retained profit 2024: € 152,468 ▼ 44% vs 2023 (€ 272,927) Unfavourable step	€ 2,170 Retained profit 2025: € 2,170 ▼ 99% vs 2024 (€ 152,468) Unfavourable step	▼ 99%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 270,000 Dividend 2024: € 270,000 Unchanged (€ 0) Unchanged	€ 292,000 Dividend 2025: € 292,000 ▲ 8% vs 2024 (€ 270,000) Unchanged	▲ 8%
Balance sheet total	€ 75,398 Balance sheet total 2022: € 75,398 First fiscal year in the series	€ 307,981 Balance sheet total 2023: € 307,981 ▲ € 232,583 vs 2022 (€ 75,398) Unchanged	€ 158,535 Balance sheet total 2024: € 158,535 ▼ 49% vs 2023 (€ 307,981) Unchanged	€ 206,861 Balance sheet total 2025: € 206,861 ▲ 30% vs 2024 (€ 158,535) Unchanged	▲ 30%

Key figures of Dr. Barbel Aspeslagh, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Barbel Aspeslagh?

What happened at Dr. Barbel Aspeslagh in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 1, 2026 New annual accounts for financial year 2025: profit of € 141,702 (▼ 5% vs 2024). Source: NBB ↗
Oct 1, 2021 New establishment in Zedelgem. KBO
Sep 28, 2021 Start of the company according to the CBE. KBO

In short

From € 37,850 profit in 2022 to € 141,702 profit in 2025.

Paid € 168,930 in corporate taxes since 2022.

Best year ever: 2023, with € 217,252 profit.

Paid out € 562,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Barbel Aspeslagh? We notify you, reason included.

Follow Dr. Barbel Aspeslagh

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Barbel ASPESLAGH

Dr. Barbel Aspeslagh

Behind Dr. Barbel Aspeslagh is Barbel ASPESLAGH.

See the full network in the app

Directors

According to the 2025 annual accounts

Barbel ASPESLAGH

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Baesveld 6

8210 Zedelgem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0774.665.952
VAT number: BE 0774.665.952
Registered office: Baesveld 6, 8210 Zedelgem
Names & denominations: Dr. Barbel Aspeslagh
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 September 2021
Peppol: Active · Active since 18 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗